Nature Biotechnology
14, 339 - 342 (1996)
doi:10.1038/nbt0396-339
Virosomes: Cationic Liposomes Enhance Retroviral TransductionClague P. Hodgson1, *
& Fauzia Solaiman1
1Creighton Cancer Center, Dept. of Biomedical Sciences, Creighton School of Medicine, Omaha, NE 68178.
*e-mail: cphod@bluejay.creighton.edu. Retrovirus-derived vectors are overwhelmingly preferred over other methods for ex vivo gene therapy because they provide permanent integration of foreign genes into cellular DNA. In comparison, cationic lipids mediate efficent gene transfer, but expression is transient. When we combined cationic lipids with retrovirus particles we obtained a significant enhancement of transduction efficiency, depending upon the type of lipid formulation and the dose used. The relative effectiveness of these cytofectins was: DOSPA:DOPE>DOTMA:DOPE>DOTAP, resulting in 60-, 37-, and 5-fold increases in transduction efficiency, respectively, at optimum dosage. The effect of polycationic DOSPA:DOPE was dependent upon the viral envelope glycoprotein, was attainable by lipid treatment of either cells or virus particles, was not enhanced by the addition of polybrene, and was inhibited by chloroquine. These results strongly suggested that DOSPA:DOPE act primarily by modulation of charge associated with the viral envelope and cell membrane, enhancing retroviral transduction, rather than by providing an alternative pathway of transfection. DOSPA:DOPE is useful for improving the efficiency of gene transfer as well as the sensitivity with which retroviruses can be detected in biological fluids.
REFERENCES
- Hodgson, C.P., 1995. The vector void in gene therapy. Bio/Technology 13: 222−225. | PubMed | ISI | ChemPort |
- Curiel, D.T., Agarwal, S. and Wagner, E. and Cotten, M. 1991. Adenovirus enhancement of transferrin-mediated gene delivery. Proc. Natl. Acad. Sci. USA 88: 8850−8854. | PubMed | ChemPort |
- Curiel, D.T., Wagner, E., Cotten, M., Birnstiel, M.L., Agarwal, S., Li, C., Loechel, S. and Hu, P. 1992. High efficiency in vitro gene transfer mediated by adenovirus coupled to DNA-polylysine complexes via an antibody bridge. Hum. Gene Ther. 3: 147−154. | PubMed | ISI | ChemPort |
- Kasahara, N., Dozy, A.M. and Kan, Y.W. 1994. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 226: 1373−1375.
- Jolly, D. and Barber, J. 1992. Helper cells. World Intellectual Property Organization (WIPO) patent publication WO92/05266.
- Wu, G.Y. and Wu, C.H. 1992. Targeting viruses and cells for selective internalization by cells. World Intellectual Property Organization (WIPO) patent publication WO92/06180.
- Yee, J.-K., Mkyanohara, A., LaPorte, P., Bouic, K., Burns, J.C. and Friedman, T. 1994. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91: 9564−9568. | PubMed | ChemPort |
- Debs, R.J. and Zhu, N. 1993. In vivo gene therapy with intron-free sequence of interest. World Intellectual Property Organization (WIPO) Publication WO93/25673.
- Wilson, T., Papahadjopoulos, D. and Taber, R. 1977. Biological properties of poliovirus encapsulated in lipid vesicles: Antibody resistance and infectivity in virus-resistant cells. Proc. Natl. Acad. Sci. USA 74: 3471−3475. | PubMed | ChemPort |
- Faller, D.V. and Baltimore, D. 1984. Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J. Virol. 49: 269−272. | PubMed | ISI | ChemPort |
- Lasic, D.D. and Papahadjopoulos, D. 1995. Liposomes revisited. Science 267: 1275−1276. | PubMed | ISI | ChemPort |
- Kondorosi, E. and Duda, E. 1982. Infection of cells with Sindbis virus nucleocapsids entrapped into liposomes. Biochem. Biophys. Res. Commun. 107: 367−373. | PubMed | ISI | ChemPort |
- Wilson, T., Papahadjopoulos, D. and Taber, R. 1977. Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc. Natl. Acad. Sci. USA 74: 3471−75. | PubMed | ChemPort |
- Konopka, K., Davis, B.R., Larsen, C.E., Alford, D.R., Debs, R.J. and Duzgunes, J. 1990. Liposomes modulate human immunodeficiency virus infectivity. J. Gen. Virol. 71: 2899−2907. | PubMed | ISI | ChemPort |
- Innes, C.L., Smith, B., Langenback, R., Tindall, K.R. and Boone, L.R. 1990. Cationic liposomes (Lipofectin) mediate retroviral infection in the absence of specific receptors. J. Virol. 64: 957−961. | PubMed | ISI | ChemPort |
- Feigner, J.H., Kumar, R., Sridhar, C.N., Wheeler, C.J., Tsai, Y.J., Border, R., Ramsey, P., Martin, M. and Feigner, P.L. 1994. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269: 2550−2561. | PubMed | ISI | ChemPort |
- Price, J., Turner, D. and Cepko, C. 1987. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84: 156−160. | PubMed | ChemPort |
- Miller, A.D. and Buttimore, C. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6: 2895−2902. | PubMed | ISI | ChemPort |
- Markowitz, D., Goff, S. and Bank, A. 1988. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62: 1120−1124. | PubMed | ISI | ChemPort |
- Chakraborty, A.K., Zink, M.A. and Hodgson, C.P. 1995. Expression of VL30 vectors in human cells that are targets for gene therapy. Biochem. Biophys. Res. Commun. 209: 677−683. | Article | PubMed | ISI | ChemPort |
|
